Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CogUK: Cerebral Function in HIV-1 Treatment Naive Subjects
NCT01367236Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Jan 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of maraviroc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Imperial College London. Started Jan 2013; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01367236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01367236.